ReviewClinical rheumatology2012

Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review.

Shunsuke Mori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.